Debut Plus

₹18.58

▲ +0.88 +4.97%

10 Sept 2026

BSE Listed

ST-ASM · ASM 1
What does ST-ASM · ASM 1 mean?
BSE · Short Term Additional Surveillance Measure (ASM 1)ST-ASM catches short bursts: a beta-adjusted close-to-close move beyond ±25% in 5 trading days (or ±40% in 15) combined with concentrated trading — or a 75%+ monthly range with fewer than 100–200 unique traders. Practical meaning: margins jump to 50–100% for a few weeks to cool a spike; it either lapses quickly or escalates into LT-ASM if the move sustains.Criteria: Short-term (5 / 15 / 30-day) price-volume abnormality — high-low and close-to-close price variation over the window. Adds 100% margin and a 5% (then 2%) price band.Exchange notice · 2026-08-03

Bacil Pharma Ltd. (524516)

Volume: 1,13,486Avg Vol 1W: 48,655Avg Vol 1M: 1,22,32052W Range:₹10.65₹61.8
BSE www.bacilpharma.co.in AI Report
Key Ratios
Checked 3h ago
Market Cap₹26 Cr
Current Price₹18.58
Previous Close₹17.7
High / Low (52w)₹61.8 / ₹10.65
Volume1,13,486
Avg Vol (1W)48,655
Avg Vol (1M)1,22,320
Stock P/E39.11
Book Value₹17.55
Dividend Yield0%
ROE6.27%
ROA237.31%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.46
P/B1.02
Debt / Equity0.01
50 DMA₹22.37
200 DMA₹40.15
Day change+4.97%
SurveillanceST-ASM · ASM 1
Price Chart
₹18.58▼ 44.12% · 1Y
₹60₹1115.1L
2025-09-15
2026-09-10

20-day avg volume: 1.3L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 87% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr
EPS-0.58-0.54-0.41-6.55-0.17-0.10.641.11
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹5 Cr₹4 Cr₹4 Cr₹1 Cr₹1 Cr₹1 Cr₹26 Cr₹27 Cr
Total Liabilities₹3 Cr₹3 Cr₹3 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr
Equity₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹25 Cr₹25 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Investing₹1 Cr₹4 Cr₹0 Cr₹0 Cr₹0 Cr₹-2 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹-1 Cr
Free Cash Flow₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE4%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-06-30

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders7,326
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Jul 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters42.7%42.7%42.7%20.7%10.6%0.2%0.2%0.1%0.1%0.1%0%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public57.3%57.3%57.3%79.3%89.4%99.8%99.8%99.9%99.9%99.9%100%100%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%——
No. of Shareholders6,6286,7706,7946,9027,4617,6387,5327,5417,4317,4317,2267,326
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Vicky Pratapbhai ShahPublic Shareholding16.6%23,81,708
Nikita Hiren PatelPublic Shareholding10.1%14,44,844
Manubhai Amrutlal ShahPublic Shareholding9.9%14,15,190
Chhaya Gaurang ShahPublic Shareholding6.7%9,55,413
Niraj Rajnikant ShahPublic Shareholding6.4%9,25,000
Manmohan Jagdishprasad GhuwalewalaPublic Shareholding4.2%6,00,000
Navin Keshrimal MehtaPublic Shareholding2.2%3,11,781
Vishal Mahesh WaghelaPublic Shareholding2.1%3,00,000
Deepa Navin MehtaPublic Shareholding1.7%2,49,980
Hemang Rajendra DoshiPublic Shareholding1.7%2,47,252
0Public Shareholding1.2%1,67,380
Saroj Kishor MehtaPublic Shareholding1.2%1,65,861
Dinesh Ishvarbhai LalwaniPublic Shareholding1.1%1,51,273
Suman P ShahShareholding of Promoter and Promoter Group0%0
Lal Lachhmandas HingoraniShareholding of Promoter and Promoter Group0%0
Prakash ShahShareholding of Promoter and Promoter Group0%0
Prakash Shah HufShareholding of Promoter and Promoter Group0%0
Shakuntala ShahShareholding of Promoter and Promoter Group0%0
Gulecha Investment & Trading Co Pvt LtdShareholding of Promoter and Promoter Group0%0
Khem Sum Apparels Overseas LimitedShareholding of Promoter and Promoter Group0%0
Sanmitra Commercial LimitedShareholding of Promoter and Promoter Group0%0
Rapport Investment & Trading Company Private LimitedShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Chaitali Kalpataru ShahExecutive Director & CFO2025
Dinesh Chander NotiyalIndependent Non Exe. Director2025
Avani Savjibhai GodhaniyaIndependent Non Exe. Director2025
Vivek Mukesh YadavIndependent Non Exe. Director2025
Tak Bhavana TakCompany Sec. & Compli. Officer2025
Aayush ShahIndependent Director2025
Ankitkumar Surendrakumar AgrawalIndependent Director2025
Mahesh SinghDirector2025
Mr. Anil Shiv Charan SinghDirector2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201314
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
forthcoming2026-07-09Board Meetings—
Substantial Acquisitions (SAST)

10 disclosure(s)

Market22/06/2026 - 24/06/2026 · 9,25,000
Market23/06/2026 - 24/06/2026 · 3,94,893
Market22/06/2026 - 23/06/2026 · 10,19,052
Market10/06/2026 · 8,00,000
Market08/06/2026 - 09/06/2026 · 3,26,104
Off Market19/02/2026 · 20,75,000
Company Information
Incorporated1987
AuditorLaxmikant Kabra & Co LLP
Investor Email[email protected]
🌐 www.bacilpharma.co.in ↗

📍 G2 & G3 Samarpan Complex, chakala Andheri East, Mumbai, Maharashtra, 400099

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Riddhi Siddhi Gluco Biols Ltd.SVC Industries LimitedRaaj Medisafe India Ltd.Revati Media LimitedCoral Laboratories Ltd.Tulasee Bio-Ethanol Ltd.Krebs Biochemicals & IndustriesKMC Speciality Hospitals (India) Ltd.Laffans Petrochemicals Ltd.Bhaskar Agrochemicals Ltd.Sukhjit Starch & ChemicalsSharma East India Hosp and Medical Research Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search